| Management of chronic heart failure guided by individual N-terminal pro–B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided … LWM Eurlings, PEJ van Pol, WE Kok, S van Wijk, ... Journal of the American College of Cardiology 56 (25), 2090-2100, 2010 | 241 | 2010 |
| Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction S Sanders‐van Wijk, V van Empel, N Davarzani, MT Maeder, ... European journal of heart failure 17 (10), 1006-1014, 2015 | 232 | 2015 |
| Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study S Sanders-van Wijk, J Tromp, L Beussink-Nelson, C Hage, S Svedlund, ... Circulation 142 (21), 2029-2044, 2020 | 135 | 2020 |
| Validation of the HFA‐PEFF score for the diagnosis of heart failure with preserved ejection fraction A Barandiarán Aizpurua, S Sanders‐van Wijk, HP Brunner‐La Rocca, ... European journal of heart failure 22 (3), 413-421, 2020 | 135 | 2020 |
| Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis MR Hazebroek, MJ Kemna, S Schalla, S Sanders-van Wijk, SC Gerretsen, ... International journal of cardiology 199, 170-179, 2015 | 129 | 2015 |
| Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening LNL Van Aelst, S Voss, P Carai, R Van Leeuwen, D Vanhoutte, ... Circulation research 116 (3), 425-436, 2015 | 91 | 2015 |
| Natriuretic peptides in chronic heart failure HP Brunner-La Rocca, S Sanders-van Wijk Cardiac failure review 5 (1), 44, 2019 | 86 | 2019 |
| Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy JAJ Verdonschot, MR Hazebroek, P Wang, S Sanders-van Wijk, ... Circulation: Heart Failure 11 (11), e005220, 2018 | 63 | 2018 |
| The HFA‐PEFF and H2FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction S Sanders‐van Wijk, AB Aizpurua, HP Brunner‐La Rocca, ... European journal of heart failure 23 (5), 838, 2021 | 61 | 2021 |
| Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical … S Sanders-van Wijk, ADI van Asselt, H Rickli, W Estlinbaum, P Erne, ... JACC: Heart Failure 1 (1), 64-71, 2013 | 59 | 2013 |
| Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score LW Eurlings, S Sanders-van Wijk, R van Kimmenade, A Osinski, ... Journal of the American College of Cardiology 60 (17), 1668-1677, 2012 | 54 | 2012 |
| Long-Term Results of Intensified, N-Terminal-Pro-B-Type Natriuretic Peptide–Guided Versus Symptom-Guided Treatment in Elderly Patients With Heart Failure: Five-Year Follow-Up … S Sanders-van Wijk, MT Maeder, F Nietlispach, H Rickli, W Estlinbaum, ... Circulation: Heart Failure 7 (1), 131-139, 2014 | 50 | 2014 |
| Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: a multicenter study J Lupón, S Sanders-van Wijk, JL Januzzi, M De Antonio, HK Gaggin, ... International journal of cardiology 204, 242-247, 2016 | 38 | 2016 |
| Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea S van Wijk, L Jacobs, LW Eurlings, R van Kimmenade, R Lemmers, ... Clinical chemistry 58 (1), 284-292, 2012 | 28 | 2012 |
| Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data N Marcks, A Aimo, JL Januzzi, G Vergaro, A Clerico, R Latini, J Meessen, ... Clinical Research in Cardiology 110, 1280-1291, 2021 | 26 | 2021 |
| Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems V Parcha, G Malla, R Kalra, N Patel, S Sanders‐van Wijk, A Pandey, ... ESC Heart Failure 8 (3), 2089-2102, 2021 | 26 | 2021 |
| Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME‐CHF trial R Stöhr, VM Brandenburg, GH Heine, MT Maeder, G Leibundgut, A Schuh, ... European journal of heart failure 22 (4), 701-709, 2020 | 26 | 2020 |
| Insulin-like growth factor binding protein 2 predicts mortality risk in heart failure M Barutaut, P Fournier, WF Peacock, MF Evaristi, C Caubère, A Turkieh, ... International Journal of Cardiology 300, 245-251, 2020 | 26 | 2020 |
| Risk stratification with the use of serial N-terminal Pro–B-Type natriuretic peptide measurements during admission and early after discharge in heart failure patients: Post hoc … LW Eurlings, S Sanders-van Wijk, DJW van Kraaij, R van Kimmenade, ... Journal of Cardiac Failure 20 (12), 881-890, 2014 | 25 | 2014 |
| Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure … S Sanders-van Wijk, S Muzzarelli, M Neuhaus, S Kiencke, M Maeder, ... European journal of heart failure 15 (8), 910-918, 2013 | 25 | 2013 |
